Científicos andaluces logran una «huella molecular» en glóbulos blancos que ofrece mejoras a ser consideradas en los próximos años
Read moreCancer remains a leading cause of death worldwide. Sartorius helps to simplify the development and manufacturing of personalized cancer therapies.
Read moreA research team from the Universitat Autònoma de Barcelona (UAB) has developed a diagnostic test based on biomarkers for better protection against exposure to micro- and nanoplastics (MNPLs). The too...
Read moreCada 4 de febrero, con motivo del Día Mundial contra el Cáncer, desde CIC bioGUNE se sumamos a la comunidad internacional para concienciar sobre la importancia de la investigación científica en...
Read moreThis is the finding of a multidisciplinary study by Pompeu Fabra University, which has studied in detail the response of lung cancer to immunotherapeutic drugs in experimental treatments with mice.
Read moreViva In Vitro Diagnostics, compañía biomédica española especializada en medicina inmunológica y en el desarrollo de soluciones innovadoras basadas en el inflamasoma NLRP3, ha incorporado al Prof....
Read moreA recent study from the Hospital del Mar Research Institute shows that cannabis use is associated with increased brain inflammation, which may affect the therapeutic effectiveness of antipsychotic tre...
Read moreAn international research team has identified metabolic changes in oral cells during infection by Candida albicans. This discovery opens new possibilities for developing more effective antifungal ther...
Read moreUn estudio internacional, liderado por el Centro de Investigación Biomédica en Red (CIBER) en el que han participado 60 expertas y expertos establece la hoja de ruta para la investigación clínica ...
Read moreThe ACE2-Fc protein shows a strong ability to block the most evolved variants of the virus and maintains its effectiveness against mutations that have reduced the impact of other antibodies
Read moreAn international study led by the University of Edinburgh, with the participation of the IDIBAPS Translational Research in Hepatic Oncology group, and published in Nature Genetics, has solved a key qu...
Read moreOryzon Genomics announced today that the first patient has been dosed in an investigator-initiated Phase Ib dose-finding trial evaluating iadademstat, Oryzon’s potent and selective LSD1 inhibitor, i...
Read more